CAJ | 학술논문

近年来,尽管动脉瘤性蛛网膜下腔出血(subarachnoid hemorrhage,SAH)的治疗取得了长足进步,但其病死率和致残率并未得到有效控制.SAH后缺血性脑损伤被认为是患者预后不良的重要原因,但其发生机制尚未完全阐明.研究表明,SAH后脑微循环障碍与缺血性脑损伤的发生密切相关.文章就SAH后脑微循环障碍与缺血性脑损伤的研究进展进行了综述.
근년래,진관동맥류성주망막하강출혈(subarachnoid hemorrhage,SAH)적치료취득료장족진보,단기병사솔화치잔솔병미득도유효공제.SAH후결혈성뇌손상피인위시환자예후불량적중요원인,단기발생궤제상미완전천명.연구표명,SAH후뇌미순배장애여결혈성뇌손상적발생밀절상관.문장취SAH후뇌미순배장애여결혈성뇌손상적연구진전진행료종술.
Although the treatment of aneurysmal subarachnoid hemorrhage (SAH) has made considerable progress in recent years,its mortality and disability have not been effectively controlled.Ischemic brain injury after SAH is considered to be an important reason for the poor prognosis of patients; however,its mechanism is still not fully understood.Studies have shown that the cerebral microcirculation disturbance after SAH is closely associated with ischemic brain injury.This article reviews the advances in research on cerebral microcirculation disturbance and ischemic brain injury after SAH.